Prialt Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 34

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Prialt General Information

Description

Developer of a non-opioid intrathecal therapy designed to reduce severe chronic pain in adult patients. The company's medicines work on pain transmission by binding to the N-type calcium channels in the spinal cord that send pain signals, enabling patients to reduce chronic pain.

Contact Information

Website
www.prialt.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • United States
Primary Industry
Pharmaceuticals
Parent Company
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Prialt Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Prialt‘s full profile, request access.

Request a free trial

Prialt Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prialt Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Prialt‘s full profile, request access.

Request a free trial

Prialt FAQs

  • Where is Prialt headquartered?

    Prialt is headquartered in .

  • What is the size of Prialt?

    Prialt has 34 total employees.

  • What industry is Prialt in?

    Prialt’s primary industry is Pharmaceuticals.

  • Is Prialt a private or public company?

    Prialt is a Private company.

  • What is Prialt’s current revenue?

    The current revenue for Prialt is .

  • Who are Prialt’s investors?

    Elan (Pharmaceuticals), Jazz Pharmaceuticals, and Tersera Therapeutics have invested in Prialt.

  • When was Prialt acquired?

    Prialt was acquired on 12-Mar-2026.

  • Who acquired Prialt?

    Prialt was acquired by Esteve Healthcare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process